Loss of host tissue transglutaminase boosts antitumor T cell immunity by altering STAT1/STAT3 phosphorylation in ovarian cancer
Guardado en:
Autores principales: | Bin Zhang, Hao Huang, Cristina Ivan, Siqi Chen, Livia Elena Sima, Horacio Cardenas, Guangyuan Zhao, Yinu Wang, Daniela Matei |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9953516a4dce45178c778aa3b3cc2cfa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Deregulated Gab2 phosphorylation mediates aberrant AKT and STAT3 signaling upon PIK3R1 loss in ovarian cancer
por: Xinran Li, et al.
Publicado: (2019) - Stat
-
The impact of STAT3 and phospho-STAT3 expression on the prognosis and clinicopathology of ovarian cancer: a systematic review and meta-analysis
por: Shuo Gao, et al.
Publicado: (2021) - JAK-STAT
-
Identification of New Shikonin Derivatives as Antitumor Agents Targeting STAT3 SH2 Domain
por: Han-Yue Qiu, et al.
Publicado: (2017)